A two-way ANOVA with repeated measures revealed significant effects of drug treatments and interactions between categories and treatments (F2,57 = 0.867, p = 0.426 for categories [NS vs. SEM vs. SNT]; F4,228 = 20.46, p < 0.001 for treatments [SAL1 vs. SAL2 vs. SCH vs. l-SUL vs. h-SUL]; F8,228 = 4.859, p < 0.001 for interaction [categories × treatments]; Fig. 3a). This evidence concerns the gene SALL2 and spindle cell hemangioma.